FindTrial
Sign In

To evaluate the effact of metformin on the treating atypical endometrium hyperplasia with infertility and subsequent IVF outcomes

To evaluate the effact of metformin on the treating atypical endometrium hyperplasia with infertility and subsequent IVF outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONR-16009078
Enrollment
Unknown
Registered
2016-08-24
Start date
2016-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial atypical hyperplasia

Interventions

group1:MPA+MET
group 2:MPA+ placebo

Sponsors

Reproductive Hospital Affiliated to Shandong University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. women aged 20–40 years; 2. Be diagnosed with hyperplasia of endometrium; 3. patients with fertility requirements; 4. receive treated and long term follow up.

Exclusion criteria

Exclusion criteria: 1. Sever liver and kidney disease; 2. History of genital tumor; 3. History of thrombosis; 4. Take the Oral contraceptives in the past two months; 5. CA125>35U/ml; 6. POF.

Design outcomes

Primary

MeasureTime frame
complete remission rate ;—

Secondary

MeasureTime frame
Recurrence rate;live birth rate;pregnancy rate;implantation rate;partial remission rate ;—

Countries

China

Contacts

Public ContactYan Lei

Reproductive Hospital Affiliated to Shandong University

yanleiandu@163.com+86 18660782393

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026